Evidence map›Paper›PMID 36618369›Full record

ArticleFrontiers in immunology2022

Corrigendum: Advances in CAR T-cell therapy in bile duct, pancreatic, and gastric cancers.

Qiang Feng, Baozhen Sun, Tianyi Xue, Rong Li, Chao Lin, Yongjian Gao, Liqun Sun, Yue Zhuo, Dongxu Wang

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Qiang FengDepartment of Hepatobiliary and Pancreas Surgery, China - Japan Union Hospital of Jilin University, Changchun, China.
Baozhen SunDepartment of Hepatobiliary and Pancreas Surgery, China - Japan Union Hospital of Jilin University, Changchun, China.
Tianyi XueLaboratory Animal Center, College of Animal Science, Jilin University, Changchun, China.
Rong LiLaboratory Animal Center, College of Animal Science, Jilin University, Changchun, China.
Chao LinSchool of Grain Science and Technology, Jilin Business and Technology College, Changchun, China.
Yongjian GaoDepartment of Gastrointestinal Colorectal and Anal Surgery, China-Japan Union Hospital of Jilin University, Changchun, China.
Liqun SunDepartment of Pathogenobiology, Jilin University Mycology Research Center, College of Basic Medical Sciences, Jilin University, Changchun, China.
Yue ZhuoSchool of Acupuncture-Moxi bustion and Tuina, Changchun University of Chinese Medicine, Changchun, China.
Dongxu WangLaboratory Animal Center, College of Animal Science, Jilin University, Changchun, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.3389/fimmu.2022.1025608.].

Indexed as

CAR T cellschimeric antigen receptorsdigestive tumorsimmunotherapyxenograft models

Identifiers

PMID36618369
PMCPMC9810501

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.